Aciclovir transdermal - Transport Pharmaceuticals

Drug Profile

Aciclovir transdermal - Transport Pharmaceuticals

Alternative Names: SoloVir

Latest Information Update: 31 May 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Transport Pharmaceuticals
  • Class Antivirals; Hypoxanthines; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 31 May 2012 Discontinued - Phase-III for Herpes simplex virus infections in USA (Transdermal)
  • 28 Nov 2007 Efficacy and safety data from a phase II trial (TPI-H-221) in recurrent herpes labialis released by Transport Pharmaceuticals
  • 01 May 2007 Transport Pharmaceuticals initiates dosing in a phase II trial (TPI-H-221) for recurrent herpes labialis in the US
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top